KEEP & PANTHERx® Rare Forge Innovative Partnership to Advance the Specialty Therapy Experience in the Home
April 25, 2024 PITTSBURGH – An exciting advancement for the specialty pharmacy industry, KEEP announced a strategic partnership with PANTHERx Rare, a leader in rare disease product patient access and support services in the US. This collaboration is set...
Read More
PANTHERx® Rare Continues Explosive Growth with Expansions of Pharmacy, HQ and Distribution Locations
April 25, 2024 PITTSBURGH – PANTHERx® Rare, the leader in rare disease pharmacy, patient access, and support services in the United States, is pleased to announce three new expansions that will facilitate the company’s continued growth and enhance...
Read More
PANTHERx® Rare Selected by Edenbridge Pharmaceuticals as Specialty Pharmacy for Yargesa® (miglustat 100 mg capsules)
April 1, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Edenbridge Pharmaceuticals for the distribution of Yargesa® (miglustat)...
Read More
PANTHERx® Rare Selected by Chiesi Global Rare Diseases for the Distribution of Filsuvez® (birch triterpenes) topical gel
February 7, 2024 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it was selected by Chiesi Global Rare Diseases, a business unit of the Chiesi Group, for the...
Read More
PANTHERx® Rare Pharmacy Once Again Earns Top Ranking in Quarterly MMIT Patient Satisfaction Survey
December 7, 2023 PITTSBURGH – PANTHERx Rare, the six-time winner of the Annual MMIT Patient Choice Award, once again, has the TOP Net Promoter Score for all independent specialty pharmacies in America for the Third Quarter of 2023 – the third top score...
Read More
PANTHERx® Selected by UCB as part of the Limited Specialty Pharmacy Network for RYSTIGGO® (rozanolixizumab-noli), for the Treatment of Generalized Myasthenia Gravis (gMG)
August 2, 2023 PITTSBURGH – PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce it has been selected by UCB as a limited distribution partner to provide RYSTIGGO® (rozanolixizumab-noli),...
Read More